Skip to main content
Clinical Trials/ISRCTN12890382
ISRCTN12890382
Completed
未知

Child Anxiety Treatment in the context of COVID-19 (Co-CAT): Enabling Child and Adolescent Mental Health Services (CAMHS) to provide efficient remote treatment for child anxiety problems

niversity of Oxford0 sites444 target enrollmentOctober 23, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Anxiety problems in children aged 5-12
Sponsor
niversity of Oxford
Enrollment
444
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36384704/ (added 18/11/2022) 2024 Results article in https://doi.org/10.1016/s2215-0366(23)00429-7 (added 12/02/2024)

Registry
who.int
Start Date
October 23, 2020
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Child inclusion criteria:
  • 1\. Aged 5\-12 years at intake
  • 2\. Primary problem is anxiety
  • 3\. Willing and able to assent
  • Parent/Carer inclusion criteria:
  • 1\. Has sufficient English language to complete measures/ access interventions
  • 2\. Family has access to the internet
  • 3\. Is willing and able to provide consent

Exclusion Criteria

  • Child exclusion criteria:
  • 1\. The child has co\-morbid conditions that are likely to interfere with treatment delivery, (established autism spectrum condition/ learning disability, suicidal intent/ recurrent or potentially life\-limiting self\-harm)
  • 2\. The child is identified by social services due to child protection concerns
  • Parent/Carer exclusion criteria:
  • 1\. The parent has a significant intellectual impairment or severe mental health problem that is likely to interfere with treatment delivery
  • 2\. The parents are unable to access or understand the written English language materials necessary for the interventions

Outcomes

Primary Outcomes

Not specified

Similar Trials